Stocks · Health care · Pharmaceutical Preparations

PRECIGEN, INC.

PGEN Clue Score19
United States Fiscal year ends December CIK 0001356090 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Harry Thomasian Jr.
23 Sep 2026
Chief Financial Officer
Exercised, kept
1
$1.21
$1.21
Harry Thomasian Jr.
23 Sep 2026
Chief Financial Officer
Exercised, kept
2
$0.96
$1.92
Harry Thomasian Jr.
23 Sep 2026
Chief Financial Officer
Exercised, kept
42,918
$2.33
$100.00K
Harry Thomasian Jr.
23 Sep 2026
Chief Financial Officer
Exercised, kept
10,744
$4.72
$50.71K
Dean J Mitchell
3 Mar 2021
Director
Exercised, kept
2,968
$5.69
$16.89K
Steven Frank
3 Mar 2021
Director
Exercised, kept
2,968
$5.69
$16.89K
Cesar L Alvarez
3 Mar 2021
Director
Exercised, kept
2,968
$5.69
$16.89K
Steven Frank
30 Jun 2020
Director
Exercised, kept
2,968
$3.17
$9.41K
Cesar L Alvarez
23 Jun 2020
Director
Exercised, kept
2,968
$3.17
$9.41K
Dean J Mitchell
19 Jun 2020
Director
Exercised, kept
2,968
$3.17
$9.41K
Showing 250 of 521 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 560
Amendments (4/A) skipped 1
Filings about a different issuer 37
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 6
Sales at will 194
Transactions with no price 0
Shares from compensation/vesting 141,839,534
Sales filed before the plan box existed 156
History held since 14 Jan 2011